World Clinical Drug
|
2025, 46(6): 629-631
• Article •
Application of nafamostat mesilate in a maintenance hemodialysis patient with heparin-induced thrombocytopenia: a case report and review of literature
Full
Yujia ZHU1, 2, Xuejie WANG2, Ziqiu WANG2, Wen DU1, 2, Zhenhua YANG1, Chenni GAO1, 2, *
Affiliations
- 1.Department of Nephrology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200025, China
- 2.Department of Nephrology, Luwan Branch of Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200020, China
Published: 2025-06-10
doi: 10.13683/j.wph.2025.06.015
Outline
nafamostat mesilate
/
maintenance hemodialysis
/
heparin-induced thrombocytopenia
朱羽佳, 王雪洁, 王子秋, 杜雯, 杨振华, 高琛妮.
甲磺酸萘莫司他用于维持性血液透析合并肝素诱导血小板减少症1 例并文献复习.
世界临床药物,
2025
, 46
(6)
: 629
-631
.
DOI: 10.13683/j.wph.2025.06.015
Yujia ZHU, Xuejie WANG, Ziqiu WANG, Wen DU, Zhenhua YANG, Chenni GAO.
Application of nafamostat mesilate in a maintenance hemodialysis patient with heparin-induced thrombocytopenia: a case report and review of literature[J].
World Clinical Drug,
2025
, 46
(6)
: 629
-631
.
DOI: 10.13683/j.wph.2025.06.015
Year 2025 volume 46 Issue 6
43
9
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.06.015
- Receive Date:2024-12-28
- Online Date:2026-11-09
- Published:2025-06-10